Open Access

[Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma

  • Authors:
    • Zhiyi Wang
    • Yuan Chen
    • Yanliang Lin
    • Xinxing Wang
    • Xianping Cui
    • Zhenhai Zhang
    • Guozhe Xian
    • Chengkun Qin
  • View Affiliations

  • Published online on: December 10, 2020     https://doi.org/10.3892/ijo.2020.5157
  • Pages: 278-279
  • Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2021
Volume 58 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Z, Chen Y, Lin Y, Wang X, Cui X, Zhang Z, Xian G and Qin C: [Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Int J Oncol 58: 278-279, 2021
APA
Wang, Z., Chen, Y., Lin, Y., Wang, X., Cui, X., Zhang, Z. ... Qin, C. (2021). [Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. International Journal of Oncology, 58, 278-279. https://doi.org/10.3892/ijo.2020.5157
MLA
Wang, Z., Chen, Y., Lin, Y., Wang, X., Cui, X., Zhang, Z., Xian, G., Qin, C."[Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma". International Journal of Oncology 58.2 (2021): 278-279.
Chicago
Wang, Z., Chen, Y., Lin, Y., Wang, X., Cui, X., Zhang, Z., Xian, G., Qin, C."[Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma". International Journal of Oncology 58, no. 2 (2021): 278-279. https://doi.org/10.3892/ijo.2020.5157